A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the safety and tolerability of sifalimumab in adult
participants with active systemic lupus erythematosus (SLE) or active dermatomyositis (DM) or
polymyositis (PM) who participated in the following clinical studies: MI-CP151, MI-CP152, or
MI-CP179.